Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL.
Rojek AE, Kline JP, Feinberg N, Appelbaum DE, Pu Y, Derman BA, Jakubowiak A, Kosuri S, Liu H, Nawas MT, Smith SM, Bishop MR, Riedell PA.
Rojek AE, et al. Among authors: appelbaum de.
Clin Lymphoma Myeloma Leuk. 2024 Feb;24(2):83-93. doi: 10.1016/j.clml.2023.09.005. Epub 2023 Sep 16.
Clin Lymphoma Myeloma Leuk. 2024.
PMID: 37827881